Practice patterns amongst fetal centers performing intrauterine transfusions (PACT): An international survey study.

Cordocentesis Fetal anemia Intraperitoneal transfusion Intrauterine transfusion Intravenous transfusion Percutaneous umbilical blood sampling

Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 19 02 2022
revised: 11 05 2022
accepted: 25 05 2022
pubmed: 7 6 2022
medline: 22 6 2022
entrez: 6 6 2022
Statut: ppublish

Résumé

Fetal anemia secondary to incompatibility between maternal-fetal blood types can result in hydrops and demise. Intrauterine transfusions have improved survival in experience centers. Our objective was to determine the practice patterns amongst fetal centers. Thirteen fetal centers across the world were surveyed. Results from all participating centers were recorded, analyzed, and presented as ratios. Questions on the survey were related to experience of the physician, preferred methods of transfusion, fetal surveillance, and timing of delivery. Differences amongst centers were as follows: 54% of the centers performed transfusions in operating room, the remaining did them in a clinic room or close to the operating room; 31% did not use maternal anesthesia, 31% used oral or intravenous sedation and 38% used a combination of local with oral or intravenous sedation. The similarities include: 84% performed intravenous transfusions, while 2 centers reported intraperitoneal and intracardiac transfusions were performed for very early cases; 85% of centers performed the last transfusion at 34-35 weeks and 77% electively delivered their patients at 37 weeks. Method of transfusion and delivery timing was similar in most centers; however, differences were seen in location of procedure, anesthetic coverage, and surveillance. Further assessment is needed to determine if these differences in practice have any potential neonatal effects.

Identifiants

pubmed: 35661539
pii: S0301-2115(22)00364-5
doi: 10.1016/j.ejogrb.2022.05.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-174

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Roopali Donepudi (R)

Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Fetal Center, Houston, TX, USA. Electronic address: Roopali.Donepudi@bcm.edu.

Eugenia Antolin (E)

Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Universitario La Paz, Instituto de Investigación Sanitaria Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.

Francisca Molina (F)

Department of Obstetrics and Gynecology, Hospital Universitario Clinico San Cecilio, Granada, Spain; Instituto de Investigación Biosanitaria IBS, Granada, Spain.

Nicolas Sananes (N)

Department of Obstetrics and Gynecology, Strasbourg University Hospital, Strasbourg, France; INSERM UMR-S 1121 'Biomaterials and Bioengineering', Strasbourg University, Strasbourg, France.

Asma Khalil (A)

Fetal Medicine Unit, St George's Hospital, St George's University of London, London, UK; Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St. George's University of London, Canada.

Nimrah Abbasi (N)

Fetal Medicine Unit, Department of Obstetrics and Gynecology, Mount Sinai Hospital, Toronto, Ontario, Canada.

M A Sánchez-Durán (MA)

Maternal Fetal Medicine Unit, Department of Obstetrics. Vall d'Hebron University Hospital, Autonomous University of Barcelona, Barcelona, Spain.

Kurt Hecher (K)

Department of Obstetrics and Fetal Medicine, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Isabella Fabietti (I)

Department of Obstetrics and Gynecology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.

Jean-Marie Jouannic (JM)

Fetal Medicine department and French National Referral Center of Perinatal Hemobiology, Trousseau Hospital, APHP Sorbonne University, Paris, France.

Javier U Ortiz (JU)

Division of Obstetrics and Perinatal Medicine, Department of Obstetrics and Gynecology, Technical University of Munich, Munich, Germany.

Antoni Borrell (A)

Prenatal Diagnosis Unit, Hospital Clínic de Barcelona, University of Barcelona, Barcelona, Catalonia, Spain.

Yuval Gielchinski (Y)

Fetal Therapy Helen-Schneider-Hospital for Women, Rabin Medical Center, Petah Tikva, Israel.

Magdalena Sanz Cortes (MS)

Department of Obstetrics and Gynecology, Baylor College of Medicine and Texas Children's Fetal Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH